FORGOT YOUR DETAILS?

Don Ganem, Novartis Institutes for BioMedical Research

A novel transcriptional program in KSHV infection of primary endothelial cells: implications for the pathogenesis and treatment of Kaposi’s sarcoma

TOP UA-36873340-1